Subscribe to Newsletter

Discovery & Development

Discovery & Development Small Molecules

Planning for Production Scale

| Daniel Maier

The development of an industrial process should begin right at the start – the preclinical stage.

Discovery & Development Drug Delivery

Injectable Innovation

| Roisin McGuigan

A company looks to give the humble injection an inventive makeover.

Discovery & Development Drug Delivery

Eliminating Side Effects In Silico

| Roisin McGuigan

Next-generation pain medications could improve on current opioid offerings.

Discovery & Development Analytical Science

Source of Light – and Inspiration

| Rich Whitworth

A new center for electron bio-imaging was officially opened by one of the three Nobel Prize winners.

Discovery & Development Business Practice

The Power to Change Lives

| Stephanie Vine

Sitting Down With…Danny Bar-Zohar, Global Head of Neuroscience Development at Novartis, Switzerland

Discovery & Development Business Practice

Antibody About Turn

| Sam Cobb

A promising candidate is on the verge of entering clinical development… What happens when you see an opportunity to make it even better?

Discovery & Development Ingredients

Returning to Spain

| Sponsored by CPHi

CPhI Worldwide will return on October 9-11, 2018, at the IFEMA, Feria de Madrid, Spain.

Discovery & Development Clinical Trials

Pharma Fiction

| Stephanie Vine

A new comedy series focuses on pharma and a clinical trial gone wrong.

Discovery & Development Clinical Trials

Positive Results in Alzheimer’s Trial

| Stephanie Vine

After many years of clinical trial failures in Alzheimer’s disease, pharma sees some positive results – although caution is recommended.

Discovery & Development Clinical Trials

Bringing Alzheimer’s in from the Cold

| Roisin McGuigan

With big pharma seemingly pulling out of the field, what hope remains for novel treatments for Alzheimer’s disease?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register